INmune Bio saw its stock surge 75% in after-hours trading Thursday after disclosing plans to unveil topline results from its Phase 2 Alzheimer’s trial on Monday. The company will present findings from ...

IOVA's ASCO update reiterates the value of Amtagvi in melanoma, but upcoming data in lung cancer and endometrial cancer in H2 ...

T is a Novel, Non-Aromatizing Androgen, Offering the Benefits of Testosterone Without Converting to Estradiol Addressing a ...

This was the stock's second consecutive day of losses.

Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179's Role in Advancing Higher HBsAg Loss PR Newswire DURHAM, N.C. and BEIJING ...

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

G RI Bio has announced encouraging six-week interim safety outcomes from the ongoing Phase IIa trial of the small molecule ...

Intelligent Bio Solutions to present Pharmacokinetic study data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo: New York Tuesday, July 15, 2025, 15: ...

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress Provided by GlobeNewswire Jun 11, 2025, 10 ...